These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33917301)

  • 1. Fourier-Transform Infrared Spectroscopy as a Discriminatory Tool for Myotonic Dystrophy Type 1 Metabolism: A Pilot Study.
    Mateus T; Almeida I; Costa A; Viegas D; Magalhães S; Martins F; Herdeiro MT; da Cruz E Silva OAB; Fraga C; Alves I; Nunes A; Rebelo S
    Int J Environ Res Public Health; 2021 Apr; 18(7):. PubMed ID: 33917301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myotonic dystrophy type 1 (DM1): a triplet repeat expansion disorder.
    Kumar A; Agarwal S; Agarwal D; Phadke SR
    Gene; 2013 Jun; 522(2):226-30. PubMed ID: 23570879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and clinical characteristics of myotonic dystrophy type 1 in koreans.
    Kim SY; Kim JY; Kim GP; Sung JJ; Lim KS; Lee KW; Chae JH; Hong YH; Seong MW; Park SS
    Korean J Lab Med; 2008 Dec; 28(6):483-92. PubMed ID: 19127114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Myotonic Dystrophy Type I patient with Predominant Proximal Muscle Weakness without Action Myotonia- A Case Report and Review of Pathology.
    Wu CI; Chien YY; Lee KY
    Acta Neurol Taiwan; 2021 Sep; 30(3)():113-118. PubMed ID: 34841507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparisons of intellectual capacities between mild and classic adult-onset phenotypes of myotonic dystrophy type 1 (DM1).
    Jean S; Richer L; Laberge L; Mathieu J
    Orphanet J Rare Dis; 2014 Nov; 9():186. PubMed ID: 25424323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear Envelope Alterations in Myotonic Dystrophy Type 1 Patient-Derived Fibroblasts.
    Viegas D; Pereira CD; Martins F; Mateus T; da Cruz E Silva OAB; Herdeiro MT; Rebelo S
    Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy.
    Logigian EL; Ciafaloni E; Quinn LC; Dilek N; Pandya S; Moxley RT; Thornton CA
    Muscle Nerve; 2007 Apr; 35(4):479-85. PubMed ID: 17230537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinsonism may aggravate dysphagia in myotonic dystrophy type 1: two case reports.
    Stano S; Barp A; Bacchin R; Zuccarino R
    Acta Myol; 2023; 42(1):31-34. PubMed ID: 37091528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic Alterations in Myotonic Dystrophy Type 1 and Their Correlation with Lipin.
    Mateus T; Martins F; Nunes A; Herdeiro MT; Rebelo S
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33673200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukocyte CTG repeat length correlates with severity of myotonia in myotonic dystrophy type 1.
    Logigian EL; Moxley RT; Blood CL; Barbieri CA; Martens WB; Wiegner AW; Thornton CA; Moxley RT
    Neurology; 2004 Apr; 62(7):1081-9. PubMed ID: 15079005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myotonic Dystrophy Type 1 Clinical, Electrophysiological and Molecular Characterization: Experience at Tertiary Care Centre.
    Khadilkar S; Jagiasi K; Yadav J; Chavan SV; Soni G; Patel B
    J Assoc Physicians India; 2017 Jun; 65(6):32-37. PubMed ID: 28782311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myotonic dystrophy: emerging mechanisms for DM1 and DM2.
    Cho DH; Tapscott SJ
    Biochim Biophys Acta; 2007 Feb; 1772(2):195-204. PubMed ID: 16876389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allele length of the DMPK CTG repeat is a predictor of progressive myotonic dystrophy type 1 phenotypes.
    Overend G; Légaré C; Mathieu J; Bouchard L; Gagnon C; Monckton DG
    Hum Mol Genet; 2019 Jul; 28(13):2245-2254. PubMed ID: 31220271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic exercise mitigates disease mechanisms and improves muscle function in myotonic dystrophy type 1 mice.
    Manta A; Stouth DW; Xhuti D; Chi L; Rebalka IA; Kalmar JM; Hawke TJ; Ljubicic V
    J Physiol; 2019 Mar; 597(5):1361-1381. PubMed ID: 30628727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Afterdischarges in myotonic dystrophy type 1.
    Yang L; Chen X; Wu R
    Neurol Sci; 2024 Feb; 45(2):735-740. PubMed ID: 37584878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Myotonic Dystrophy Type 1 with Metformin.
    García-Puga M; Saenz-Antoñanzas A; Matheu A; López de Munain A
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35270043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hand-training in persons with myotonic dystrophy type 1--a randomised controlled cross-over pilot study.
    Aldehag A; Jonsson H; Lindblad J; Kottorp A; Ansved T; Kierkegaard M
    Disabil Rehabil; 2013 Oct; 35(21):1798-807. PubMed ID: 23480644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diastolic heart dysfunction is correlated with CTG repeat length in myotonic dystrophy type 1.
    Park JS; Kim N; Park D
    Neurol Sci; 2018 Nov; 39(11):1935-1943. PubMed ID: 30094526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of myotonic dystrophy and hereditary motor and sensory neuropathy.
    Kurt S; Karaer H; Kaplan Y; Akat I; Battaloglu E; Eruslu D; Basak AN
    J Neurol Sci; 2010 Jan; 288(1-2):197-9. PubMed ID: 19846120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stapedial reflex in myotonic dystrophy type 1 and CTG repeat expansion.
    Osanai R; Kinoshita M; Hirose K
    J Neurol; 2001 Dec; 248(12):1056-61. PubMed ID: 12013582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.